Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)

Hospira

Programmatic AI Search & Model Visibility Audit

Share of Model (SOM)
0.1%
+0.0% 30-Day Momentum
🧠 Neural Valency:Neutral

Algorithmic Threat Detection

Primary Competitor Threat
Baxter
Competitor Displacement Rate
0.1%

Competitors are displacing Hospira in 0.1% of high-intent buyer queries.

Algorithmic Rationale: Baxter frequently appears in top results for hospital supply and infusion therapy products, indicating a stronger algorithmic preference and broader product visibility compared to Hospira in certain clinical settings.
Missing AI Citations:
[baxter.com][bd.com]
⚠️ Identified Vulnerability:Product Range
Primary Threat Identified:Baxter
Target Persona:Hospital Procurement Managers
🚨 Threat Velocity:3/10
Unlock Full Threat Report (30 Free Credits)